23andMe plans to hold a second auction for its DNA data, opening with a $305M bid led by Anne Wojcicki, after the ex-CEO challenged Regeneron's winning May bid
Bankrupt genetic analysis company 23andMe will hold a second auction for its cache of DNA data with an opening bid of $305 million …
23andMe files for bankruptcy to “maximize the value of its business”, and co-founder and CEO Anne Wojcicki steps down; 23andMe was valued at $3.5B in June 2021
The Silicon Valley-based firm will continue marketing itself to investors with the goal of getting at least …
Analysis: in 2024, ~66% of 39 public digital health companies lost value, while the Nasdaq rose 32%; in 2021, digital health startups raised a record $29.1B
Post-pandemic demand waned, bringing down former high fliers like Teladoc (-96% from 2021 highs) and Progyny (-60% YTD). … X: Ashley Capoot / @ashleycapoot : New: It's been nearly 5 years since Covid ...
23andMe's stock, which hit a $6B valuation after a 2021 IPO, has crashed 98% and 23andMe may run out of cash by 2025, as CEO Anne Wojcicki plots a turnaround
From celebrity ‘spit parties’ to a drop in the bucket: The once-hot DNA-testing company is struggling to profit Forums: Hacker News , r/technology , and Slashdot Forums: Hacker News : 23andMe's Fall r...
SEC filing: Alphabet sold nearly 90% of its Robinhood stake as of June 30, as part of paring back large positions in public companies like 23andMe and Duolingo
Rohan Goswami / CNBC :
23andMe goes public via merger with a Richard Branson SPAC, raises $600M in IPO at a valuation of $3.5B; shares were up 21% on its first day at Nasdaq
Eric Rosenbaum / CNBC :
DNA testing company 23andMe raises ~$82.5M Series F led by Sequoia Capital and NewView Capital; the company laid off 14% of its workforce earlier this year
NEA announces a $1.35B spinout fund called NewView Capital, sells 31 of its portfolio companies including 23andMe, Duolingo, Forter, and GumGum to the new fund
Kate Clark / TechCrunch :
23andMe to receive up to $60M from pharma company Genentech to provide genetic data for Parkinson's research
Matthew Herper / Forbes :